Biologic Agents in Crohn’s Patients Reduce CD4+ T Cells Activation and Are Inversely Related to Treg Cells

Crohn’s disease (CD) is a chronic inflammatory disease with a complex interface of broad factors. There are two main treatments for Chron’s disease: biological therapy and nonbiological therapy. Biological agent therapy (e.g., anti-TNF) is the most frequently prescribed treatment; however, it is not...

Full description

Saved in:
Bibliographic Details
Main Authors: Eliane Aparecida Rosseto-Welter, Leticia D’argenio-Garcia, Filipa Blasco Tavares Pereira Lopes, Ana Eduarda Zulim Carvalho, Fernando Flaquer, Vanessa Severo-Lemos, Claudia Concer Viero Nora, Flavio Steinwurz, Lucas Pires Garcia Oliveria, Thiago Aloia, Luiz Vicente Rizzo, Cristóvão Luis Pitangueira Mangueira, Karina Inacio Carvalho
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2022/1307159
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554730777214976
author Eliane Aparecida Rosseto-Welter
Leticia D’argenio-Garcia
Filipa Blasco Tavares Pereira Lopes
Ana Eduarda Zulim Carvalho
Fernando Flaquer
Vanessa Severo-Lemos
Claudia Concer Viero Nora
Flavio Steinwurz
Lucas Pires Garcia Oliveria
Thiago Aloia
Luiz Vicente Rizzo
Cristóvão Luis Pitangueira Mangueira
Karina Inacio Carvalho
author_facet Eliane Aparecida Rosseto-Welter
Leticia D’argenio-Garcia
Filipa Blasco Tavares Pereira Lopes
Ana Eduarda Zulim Carvalho
Fernando Flaquer
Vanessa Severo-Lemos
Claudia Concer Viero Nora
Flavio Steinwurz
Lucas Pires Garcia Oliveria
Thiago Aloia
Luiz Vicente Rizzo
Cristóvão Luis Pitangueira Mangueira
Karina Inacio Carvalho
author_sort Eliane Aparecida Rosseto-Welter
collection DOAJ
description Crohn’s disease (CD) is a chronic inflammatory disease with a complex interface of broad factors. There are two main treatments for Chron’s disease: biological therapy and nonbiological therapy. Biological agent therapy (e.g., anti-TNF) is the most frequently prescribed treatment; however, it is not universally accessible. In fact, in Brazil, many patients are only given the option of receiving nonbiological therapy. This approach prolongs the subsequent clinical relapse; however, this procedure could be implicated in the immune response and enhance disease severity. Our purpose was to assess the effects of different treatments on CD4+ T cells in a cohort of patients with Crohn’s disease compared with healthy individuals. To examine the immune status in a Brazilian cohort, we analyzed CD4+ T cells, activation status, cytokine production, and Treg cells in blood of Crohn’s patients. Patients that underwent biological therapy can recover the percentage of CD4+CD73+ T cells, decrease the CD4+ T cell activation/effector functions, and maintain the peripheral percentage of regulatory T cells. These results show that anti-TNF agents can improve CD4+ T cell subsets, thereby inducing Crohn’s patients to relapse and remission rates.
format Article
id doaj-art-c02880b0ac524b9bb2c25993484305cd
institution Kabale University
issn 2291-2797
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-c02880b0ac524b9bb2c25993484305cd2025-02-03T05:50:44ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27972022-01-01202210.1155/2022/1307159Biologic Agents in Crohn’s Patients Reduce CD4+ T Cells Activation and Are Inversely Related to Treg CellsEliane Aparecida Rosseto-Welter0Leticia D’argenio-Garcia1Filipa Blasco Tavares Pereira Lopes2Ana Eduarda Zulim Carvalho3Fernando Flaquer4Vanessa Severo-Lemos5Claudia Concer Viero Nora6Flavio Steinwurz7Lucas Pires Garcia Oliveria8Thiago Aloia9Luiz Vicente Rizzo10Cristóvão Luis Pitangueira Mangueira11Karina Inacio Carvalho12Hospital Israelita Albert EinsteinHospital Israelita Albert EinsteinCase Western Reserve UniversityHospital Israelita Albert EinsteinHospital Israelita Albert EinsteinHospital Israelita Albert EinsteinHospital Israelita Albert EinsteinHospital Israelita Albert EinsteinHospital Israelita Albert EinsteinHospital Israelita Albert EinsteinHospital Israelita Albert EinsteinHospital Israelita Albert EinsteinHospital Israelita Albert EinsteinCrohn’s disease (CD) is a chronic inflammatory disease with a complex interface of broad factors. There are two main treatments for Chron’s disease: biological therapy and nonbiological therapy. Biological agent therapy (e.g., anti-TNF) is the most frequently prescribed treatment; however, it is not universally accessible. In fact, in Brazil, many patients are only given the option of receiving nonbiological therapy. This approach prolongs the subsequent clinical relapse; however, this procedure could be implicated in the immune response and enhance disease severity. Our purpose was to assess the effects of different treatments on CD4+ T cells in a cohort of patients with Crohn’s disease compared with healthy individuals. To examine the immune status in a Brazilian cohort, we analyzed CD4+ T cells, activation status, cytokine production, and Treg cells in blood of Crohn’s patients. Patients that underwent biological therapy can recover the percentage of CD4+CD73+ T cells, decrease the CD4+ T cell activation/effector functions, and maintain the peripheral percentage of regulatory T cells. These results show that anti-TNF agents can improve CD4+ T cell subsets, thereby inducing Crohn’s patients to relapse and remission rates.http://dx.doi.org/10.1155/2022/1307159
spellingShingle Eliane Aparecida Rosseto-Welter
Leticia D’argenio-Garcia
Filipa Blasco Tavares Pereira Lopes
Ana Eduarda Zulim Carvalho
Fernando Flaquer
Vanessa Severo-Lemos
Claudia Concer Viero Nora
Flavio Steinwurz
Lucas Pires Garcia Oliveria
Thiago Aloia
Luiz Vicente Rizzo
Cristóvão Luis Pitangueira Mangueira
Karina Inacio Carvalho
Biologic Agents in Crohn’s Patients Reduce CD4+ T Cells Activation and Are Inversely Related to Treg Cells
Canadian Journal of Gastroenterology and Hepatology
title Biologic Agents in Crohn’s Patients Reduce CD4+ T Cells Activation and Are Inversely Related to Treg Cells
title_full Biologic Agents in Crohn’s Patients Reduce CD4+ T Cells Activation and Are Inversely Related to Treg Cells
title_fullStr Biologic Agents in Crohn’s Patients Reduce CD4+ T Cells Activation and Are Inversely Related to Treg Cells
title_full_unstemmed Biologic Agents in Crohn’s Patients Reduce CD4+ T Cells Activation and Are Inversely Related to Treg Cells
title_short Biologic Agents in Crohn’s Patients Reduce CD4+ T Cells Activation and Are Inversely Related to Treg Cells
title_sort biologic agents in crohn s patients reduce cd4 t cells activation and are inversely related to treg cells
url http://dx.doi.org/10.1155/2022/1307159
work_keys_str_mv AT elianeaparecidarossetowelter biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells
AT leticiadargeniogarcia biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells
AT filipablascotavarespereiralopes biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells
AT anaeduardazulimcarvalho biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells
AT fernandoflaquer biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells
AT vanessaseverolemos biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells
AT claudiaconcervieronora biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells
AT flaviosteinwurz biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells
AT lucaspiresgarciaoliveria biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells
AT thiagoaloia biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells
AT luizvicenterizzo biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells
AT cristovaoluispitangueiramangueira biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells
AT karinainaciocarvalho biologicagentsincrohnspatientsreducecd4tcellsactivationandareinverselyrelatedtotregcells